Cargando…

4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice

Hepatocellular carcinoma (HCC) arises in the setting of advanced liver fibrosis, a dynamic and complex inflammatory disease. The tumor microenvironment (TME) is a mixture of cellular components including cancer cells, cancer stem cells (CSCs), tumor-associated macrophages (TAM), and dendritic cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez, Marcelo M., Onorato, Agostina, Cantero, María José, Domínguez, Luciana, Bayo, Juan, Fiore, Esteban, García, Mariana, Atorrasagasti, Catalina, Canbay, Ali, Malvicini, Mariana, Mazzolini, Guillermo D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973733/ https://www.ncbi.nlm.nih.gov/pubmed/33737571 http://dx.doi.org/10.1038/s41598-021-85491-0

Ejemplares similares

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
por: Fiore, Esteban, et al.
Publicado: (2016)

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
por: Malvicini, Mariana, et al.
Publicado: (2012)

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
por: Onorato, Agostina M., et al.
Publicado: (2023)

SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response
por: Peixoto, Estanislao, et al.
Publicado: (2016)

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018)

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice
por: Domínguez, Luciana M., et al.
Publicado: (2023)

Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice
por: Atorrasagasti, Catalina, et al.
Publicado: (2013)

Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009)

Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies
por: Fiore, Esteban Juan, et al.
Publicado: (2018)

Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis
por: Sukowati, Caecilia H. C., et al.
Publicado: (2019)

IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness
por: Bayo, Juan, et al.
Publicado: (2016)

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
por: Mazzolini, Guillermo, et al.
Publicado: (2020)

Human Umbilical Cord Perivascular Cells Exhibited Enhanced Migration Capacity towards Hepatocellular Carcinoma in Comparison with Bone Marrow Mesenchymal Stromal Cells: A Role for Autocrine Motility Factor Receptor
por: Bayo, Juan, et al.
Publicado: (2014)

Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
por: Atorrasagasti, Catalina, et al.
Publicado: (2021)

Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction
por: Rizzo, Manglio, et al.
Publicado: (2014)

Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma
por: Bayo, Juan, et al.
Publicado: (2014)

Antioxidant Activities of 4-Methylumbelliferone Derivatives
por: Al-Majedy, Yasameen K., et al.
Publicado: (2016)

Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016)

Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts
por: Galgoczi, Erika, et al.
Publicado: (2020)

Novel 4-Methylumbelliferone Amide Derivatives: Synthesis, Characterization and Pesticidal Activities
por: Wei, Yan, et al.
Publicado: (2018)

(1)H-NMR dataset for hydroxycoumarins –Aesculetin, 4-Methylumbelliferone, and umbelliferone
por: dos Santos, Rui Galhano, et al.
Publicado: (2016)

4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication
por: Saga, Ryo, et al.
Publicado: (2021)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
por: Tamura, Ryosuke, et al.
Publicado: (2014)

Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation
por: Steen, Emily H., et al.
Publicado: (2021)

4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing
por: Tsitrina, Alexandra A., et al.
Publicado: (2023)

Prevention of hepatocellular carcinoma and monitoring of high-risk patients
por: Kaya, Eda, et al.
Publicado: (2022)

4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
por: Nagy, Nadine, et al.
Publicado: (2015)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Oral treatment of 4-methylumbelliferone reduced perineuronal nets and improved recognition memory in mice
por: Dubisova, Jana, et al.
Publicado: (2022)

4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells
por: Pibuel, Matías A., et al.
Publicado: (2023)

Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo
por: Arai, E, et al.
Publicado: (2011)

Treatment with the Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone Suppresses SEB-Induced Lung Inflammation
por: McKallip, Robert J., et al.
Publicado: (2013)

Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms
por: Ismail, Sabariah, et al.
Publicado: (2010)

4-methylumbelliferone inhibits clonogenic potency by suppressing high molecular weight-hyaluronan in fibrosarcoma cells
por: Hasegawa, Kazuki, et al.
Publicado: (2020)

Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase
por: Clarkin, C.E., et al.
Publicado: (2011)

Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone as an Anti-Inflammatory Modulator of LPS-Mediated Astrocyte Responses
por: Chistyakov, Dmitry V., et al.
Publicado: (2020)

4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization
por: Andreichenko, Irina N., et al.
Publicado: (2019)

Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy
por: Vitale, Daiana L., et al.
Publicado: (2021)

4-methylumbelliferone (4-MU) enhances drought tolerance of apple by regulating rhizosphere microbial diversity and root architecture
por: Zhang, Dehui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ke4h6ijr7ujkaf9st3f80q2cg3